Y-Biologics is Korea’s leading R&D biotech company focused on antibody drug development, with a strong emphasis on immuno-oncology
Y-Biologics is Korea’s leading R&D biotech company focused on antibody drug development, with a strong emphasis on immuno-oncology. The company has developed unique platform technologies for antibody therapeutics, including a human antibody library and bispecific T-cell engager antibodies.